Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Denovium Logo
Denovium Growth Score
80
CB Rank
1172643
Heat Score
37
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma.
Acquired by
Absci Logo
Absci
Founded
obfuscation
Private San Diego, California, United States1-10 www.denovium.com/
Artificial Intelligence (AI)
Biotechnology
Overview

Denovium
Growth Score
80
Heat Score
37

Growth Score80
-10 pts
in past quarter
Heat Score 37
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Denovium

CB Rank
1172643
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma.
Acquired by
Absci Logo
Absci
Founded
obfuscation
Private San Diego, California, United States1-10 www.denovium.com/
Artificial Intelligence (AI)
Biotechnology

Key People

Details

Legal Name Denovium, Inc.
Operating Status Active
Company Type For Profit
Founders  Imad Ajjawi
About the Company
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma.
Contact Email info@denovium.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Integrated Drug Creation Platform
A platform that combines data generation, AI model creation, and wet lab validation to design and optimize biologics, reducing the time from concept to clinic.
AI Drug Creation
An iterative process using AI models and wet lab validation to design and optimize biologics, focusing on creating better biologics faster.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

Denovium was acquired by Absci on
obfuscation
.
Transaction Name 
Denovium acquired by Absci Logo
Denovium acquired by Absci
Acquired by 
Absci Logo
Absci
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jan 12, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

11Denovium is actively using 11 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Content Delivery Network, and  Cloudflare CDN.
Sub-Organizations
Frequently Asked Questions

Where is Denovium's headquarters? Denovium is located in San Diego, California, United States.Who are Denovium's competitors? Alternatives and possible competitors to Denovium may include Profluent Bio, Generate Biomedicines, and  Cradle.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|